Kovitz Investment Group Partners LLC Lowers Position in Healthpeak Properties, Inc. (NYSE:DOC)

Kovitz Investment Group Partners LLC lessened its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 83.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,078 shares of the real estate investment trust's stock after selling 69,484 shares during the period. Kovitz Investment Group Partners LLC's holdings in Healthpeak Properties were worth $285,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Principal Financial Group Inc. boosted its holdings in shares of Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after acquiring an additional 17,314,572 shares during the period. Norges Bank acquired a new position in Healthpeak Properties in the 4th quarter valued at $166,804,000. Long Pond Capital LP bought a new position in Healthpeak Properties during the 4th quarter worth $86,885,000. JPMorgan Chase & Co. boosted its position in shares of Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after acquiring an additional 4,056,931 shares during the period. Finally, National Bank of Canada FI grew its stake in shares of Healthpeak Properties by 56,120.9% in the fourth quarter. National Bank of Canada FI now owns 1,686,065 shares of the real estate investment trust's stock valued at $34,181,000 after acquiring an additional 1,683,066 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Trading Down 0.8 %

Shares of DOC stock traded down $0.14 on Tuesday, hitting $17.45. The company had a trading volume of 5,056,801 shares, compared to its average volume of 4,915,775. Healthpeak Properties, Inc. has a twelve month low of $17.33 and a twelve month high of $23.26. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The firm has a market cap of $12.12 billion, a P/E ratio of 49.84, a P/E/G ratio of 2.17 and a beta of 1.02. The stock's 50-day moving average is $19.32 and its two-hundred day moving average is $20.37.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The company had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. During the same period in the prior year, the firm posted $0.45 EPS. The company's quarterly revenue was up 15.9% on a year-over-year basis. On average, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a dividend, which was paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th were issued a $0.1017 dividend. This represents a yield of 6.5%. The ex-dividend date was Thursday, April 17th. Healthpeak Properties's payout ratio is 305.00%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on DOC shares. Argus reaffirmed a "buy" rating and issued a $25.00 price objective on shares of Healthpeak Properties in a report on Tuesday, April 29th. Morgan Stanley upgraded shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price for the company in a research report on Wednesday, January 15th. Scotiabank reduced their price target on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a research report on Friday, February 28th. Wedbush lowered their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Finally, Robert W. Baird reduced their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and an average price target of $23.42.

Insider Buying and Selling at Healthpeak Properties

In other news, CEO Scott M. Brinker acquired 11,337 shares of Healthpeak Properties stock in a transaction on Monday, April 28th. The stock was purchased at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the purchase, the chief executive officer now owns 201,863 shares of the company's stock, valued at approximately $3,568,937.84. The trade was a 5.95 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director John T. Thomas bought 4,200 shares of the stock in a transaction dated Monday, April 28th. The shares were purchased at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director now directly owns 813,566 shares of the company's stock, valued at $14,514,017.44. This trade represents a 0.52 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.23% of the company's stock.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.